SUNNYVALE, Calif., Nov. 12, 2020 /PRNewswire/ -- Accuray
Incorporated (NASDAQ: ARAY) announced today it has appointed
Jim Dennison as its senior vice
president of global quality and regulatory affairs, effective
immediately. Mr. Dennison is an accomplished quality assurance and
regulatory affairs executive with a nearly 15 year tenure at GE
Healthcare. At Accuray, he will lead overall quality, regulatory
and government affairs, along with product compliance, reporting to
Joshua H. Levine, president and
chief executive officer.
Most recently, Mr. Dennison served as senior executive vice
president, quality and regulatory affairs at GE Healthcare,
managing more than 40 global design and manufacturing sites across
12 GE Healthcare businesses, including imaging. Under his
leadership, the organization standardized a global Quality
Management System, ensuring compliance with over 25 global
regulators while simultaneously and continuously improving
product quality. Mr. Dennison was also responsible for directing
the GE Healthcare regulatory submission process and in the United States, achieved best in industry
FDA 510(k) clearance times. He also has held leadership roles with
Medtronic, Mallinckrodt Pharmaceutical and Baxter Healthcare, where
he developed and implemented quality and regulatory processes
designed to better achieve the organizations' strategic
objectives.
"Jim Dennison is a highly
respected executive recognized throughout the medical device
industry for his expertise. We are thrilled to have someone of his
caliber join the Accuray team and lead the advancement of our
quality and regulatory affairs function. We are confident in Jim's
ability to build the global teams, operations and infrastructure
required to support the strategic R&D investments and market
expansion opportunities that will drive the growth of our
business," said Joshua H. Levine,
president and chief executive officer of Accuray.
About Accuray
Accuracy is committed to expanding the powerful potential of
radiation therapy to improve as many lives as possible. We invent
unique, market-changing solutions to deliver radiation treatments
for even the most complex cases—while making commonly treatable
cases even easier—to meet the full spectrum of patient needs. We
are dedicated to continuous innovation in radiation therapy for
oncology, neuro-radiosurgery, and beyond, as we partner with
clinicians and administrators, empowering them to help patients get
back to their lives, faster. Accuray is headquartered in
Sunnyvale, California, with
facilities worldwide. To learn more, visit www.accuray.com or
follow us on Facebook, LinkedIn, Twitter and YouTube.
Investor Contact:
Joe Diaz
Investor Relations, Lytham Partners
+1 (602) 889-9700
diaz@lythampartners.com
Media Contact:
Beth
Kaplan
Accuray
+1 (408)
789-4426
bkaplan@accuray.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/accuray-appoints-renowned-medical-device-industry-executive-jim-dennison-as-senior-vice-president-of-global-quality-and-regulatory-affairs-301171692.html
SOURCE Accuray Incorporated